RNA-Based Classification of Homologous Recombination Deficiency in Racially Diverse Patients with Breast Cancer.

Journal Information

Full Title: Cancer Epidemiol Biomarkers Prev

Abbreviation: Cancer Epidemiol Biomarkers Prev

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Biochemistry

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"tcga data can be downloaded through the genomic data commons at https://portal gdc cancer gov while mouse-specific and scan-b expression data are available on gene expression omnibus accession numbers and gse96058.; metabric expression data are available after application to the international cancer genome consortium data access committee in the european genome-phenome archive accession numbers egad00010000210 and egad00010000211."

Code Sharing
Evidence found in paper:

"Authors' Disclosures S.C. Van Alsten reports grants from National Cancer Institute during the conduct of the study. G.P. Gupta reports grants from National Cancer Institute during the conduct of the study, grants from V foundation, and grants from ASTRO/BCRF outside the submitted work. C.M. Perou reports grants from NCI Breast SPORE program P50-CA58223 during the conduct of the study, personal fees from Bioclassifier, LLC. outside the submitted work as well as a patent for U.S. Patent No. 12,995,459 issued, licensed, and with royalties paid from Bioclassifier. No disclosures were reported by the other authors."

Evidence found in paper:

"We are grateful to CBCS participants for their generous participation, as well as study staff. The authors would like to acknowledge the UNC-CH BioSpecimen Processing Facility for sample processing, storage, and sample disbursements (http://bsp.web.unc.edu/). This work and the CBCS was supported by a grant from UNC Lineberger Comprehensive Cancer Center (Chapel Hill, NC), which is funded by the University Cancer Research Fund of North Carolina, the Susan G. Komen Foundation (OGUNC1202 and TREND21686258 to M.A. Troester), and the NCI of the NIH (P01CA151135, to M.A. Troester), including the NCI Specialized Program of Research Excellence (SPORE) in Breast Cancer (P50CA058223, to C.M. Perou, M.A. Troester, and K.A. Hoadley). In addition, this work was supported by R01CA253450 (to M.A. Troester and K.A. Hoadley), F31CA257388 (to A.M. Hamilton), Komen Career Catalyst grant (CCR16376756, to K.A. Hoadley), and UNC-CH Cancer Control Education Program (T32CA057726, to A. Walens and S. Van Alsten). This research recruited participants and/or obtained data with the assistance of Rapid Case Ascertainment, a collaboration between the North Carolina Central Cancer Registry and UNC Lineberger Comprehensive Cancer Center. Rapid Case Ascertainment is supported by a grant from the NCI of the NIH (grant no. P30CA016086). The Pathology Services Core is supported in part by NCI of the NIH Center Core Support Grant (P30CA016080) and the UNC-CH University Cancer Research Fund."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025